Suvasini Lakshmanan1, Matthew Jankowich2, Wen-Chih Wu1, Siddique Abbasi1, Alan R Morrison1, Gaurav Choudhary1. 1. Division of Cardiology, Providence VA Medical Center, Alpert Medical School of Brown University, Providence, RI, USA. 2. Division of Pulmonary, Critical Care and Sleep Medicine, Providence VA Medical Center and Alpert Medical School of Brown University, Providence, RI, USA.
Abstract
BACKGROUND: Adiponectin is a polypeptide hormone related to obesity, and a known modulator of pulmonary vascular remodeling. Association between plasma adiponectin levels and pulmonary hypertension (PH) has not been studied in African Americans (AAs) who are disproportionately affected by obesity. The relationship between adiponectin and heart failure (HF) and mortality, outcomes associated with PH, is unclear. METHODS: We performed cross-sectional and longitudinal analysis to examine if there is an association between plasma adiponectin and PH and associated clinical outcomes, in participants of Jackson Heart Study (JHS). JHS is a prospective observational cohort study of heart disease in AAs from Jackson, Mississippi. RESULTS: Of the 3161 participants included in the study, mean age (SD) was 56.38 (12.61) years, 1028 were men (32.5%), and mean (SD) BMI was 31.42 (7.05) kg/m2. Median (IQR) adiponectin was 4516.82 (2799.32-7065.85) ng/mL. After adjusting for potential confounders including BMI, higher adiponectin levels were associated with increased odds of PH (adjusted odds ratio per log increment in adiponectin, (1.81; 95% CI, 1.41-2.32). High adiponectin levels were also associated with associated HF admissions (adjusted hazard ratio [HR] per log increment in adiponectin, 1.63, 95% CI, 1.24-2.14) and mortality (adjusted HR per log increment in adiponectin, 1.20; 95% CI 1.02-1.41). CONCLUSIONS: Elevated plasma adiponectin levels are associated with PH, HF admissions and mortality risk in AAs. High adiponectin levels may help identify an at-risk population that could be evaluated for targeted prevention and management strategies in future studies.
BACKGROUND: Adiponectin is a polypeptide hormone related to obesity, and a known modulator of pulmonary vascular remodeling. Association between plasma adiponectin levels and pulmonary hypertension (PH) has not been studied in African Americans (AAs) who are disproportionately affected by obesity. The relationship between adiponectin and heart failure (HF) and mortality, outcomes associated with PH, is unclear. METHODS: We performed cross-sectional and longitudinal analysis to examine if there is an association between plasma adiponectin and PH and associated clinical outcomes, in participants of Jackson Heart Study (JHS). JHS is a prospective observational cohort study of heart disease in AAs from Jackson, Mississippi. RESULTS: Of the 3161 participants included in the study, mean age (SD) was 56.38 (12.61) years, 1028 were men (32.5%), and mean (SD) BMI was 31.42 (7.05) kg/m2. Median (IQR) adiponectin was 4516.82 (2799.32-7065.85) ng/mL. After adjusting for potential confounders including BMI, higher adiponectin levels were associated with increased odds of PH (adjusted odds ratio per log increment in adiponectin, (1.81; 95% CI, 1.41-2.32). High adiponectin levels were also associated with associated HF admissions (adjusted hazard ratio [HR] per log increment in adiponectin, 1.63, 95% CI, 1.24-2.14) and mortality (adjusted HR per log increment in adiponectin, 1.20; 95% CI 1.02-1.41). CONCLUSIONS: Elevated plasma adiponectin levels are associated with PH, HF admissions and mortality risk in AAs. High adiponectin levels may help identify an at-risk population that could be evaluated for targeted prevention and management strategies in future studies.
Authors: Herman A Taylor; James G Wilson; Daniel W Jones; Daniel F Sarpong; Asoka Srinivasan; Robert J Garrison; Cheryl Nelson; Sharon B Wyatt Journal: Ethn Dis Date: 2005 Impact factor: 1.847
Authors: Evan L Brittain; Meredith S Duncan; Joyce Chang; Olga V Patterson; Scott L DuVall; Cynthia A Brandt; Kaku A So-Armah; Matthew Goetz; Kathleen Akgun; Kristina Crothers; Courtney Zola; Joon Kim; Cynthia Gibert; Margaret Pisani; Alison Morris; Priscilla Hsue; Hilary A Tindle; Amy Justice; Matthew Freiberg Journal: Am J Respir Crit Care Med Date: 2018-04-01 Impact factor: 21.405
Authors: An M Van Berendoncks; Anne Garnier; Paul Beckers; Vicky Y Hoymans; Nadine Possemiers; Dominique Fortin; Wim Martinet; Viviane Van Hoof; Christiaan J Vrints; Renée Ventura-Clapier; Viviane M Conraads Journal: Circ Heart Fail Date: 2010-01-26 Impact factor: 8.790